Updated daily
| # | PubMedId | Deleted | Publication |
|---|---|---|---|
| 41211763 | 0 | Wang TF, Yeo E, Gross PL, et al. A Multicenter Prospective Cohort Study on the Use of Weight-Adjusted Dalteparin in Patients Over 90 kg With Acute Cancer-Associated Venous Thromboembolism-The WAVe Study. Am J Hematol. 2025 Nov 10. doi: 10.1002/ajh.70127. | |
| 41065579 | 0 | Delluc A, Carrier M, Lauw M, et al. Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey. Blood Coagul Fibrinolysis. 2025 Oct 6. doi: 10.1097/MBC.0000000000001388. | |
| 37091135 | 0 | Roberge G, Samson C, Le Gal G, et al. Prolonged Fasting as a Cause of Deep Vein Thrombosis: A Case Report. TH Open. 2023 Apr 20;7(2):e94-e96. doi: 10.1055/s-0043-57225. eCollection 2023 Apr. | |
| 36709677 | 0 | Roberge G, Carrier M. Long VITT: A case report. Thromb Res. 2023 Jan 24;223:78-79. doi: 10.1016/j.thromres.2023.01.017. | |
| 35787808 | 0 | Roberge G, Cote B, Calabrino A, et al. Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases. Thromb J. 2022 Jul 4;20(1):38. doi: 10.1186/s12959-022-00398-8. | |
| 35275495 | 0 | Roberge G, Carrier M. Persistence of Platelets Activation Prior to Second Doses of Covid-19 Vaccine After Vaccine-Induced Immune Thrombotic Thrombocytopenia. Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221086283. doi: 10.1177/10760296221086283. | |
| 34327829 | 0 | Roberge G. May-Thurner syndrome prevalence as a risk factor for acute deep vein thrombosis is unknown. J Thromb Haemost. 2021 Aug;19(8):2093. doi: 10.1111/jth.15398. | |
| 34327827 | 0 | Roberge G, D'Astous J, Rodger M. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al. J Thromb Haemost. 2021 Aug;19(8):2091-2092. doi: 10.1111/jth.15369. | |
| 34233107 | 0 | Patriquin CJ, Laroche V, Selby R, et al. Therapeutic Plasma Exchange in Vaccine-Induced Immune Thrombotic Thrombocytopenia. N Engl J Med. 2021 Aug 26;385(9):857-859. doi: 10.1056/NEJMc2109465. Epub 2021 Jul 7. | |
| 33794913 | 0 | Roberge G, Wells PS. Apixaban anti-Xa level monitoring in treatment of acute upper extremity deep vein thrombosis for patient on chronic hemodialysis: a case report. Thromb J. 2021 Apr 1;19(1):23. doi: 10.1186/s12959-021-00277-8. | |
| 33190023 | 0 | Roberge G, Delluc A. Challenging anticoagulation cases: A case of incidental subsegmental pulmonary embolism in a patient with cancer. Thromb Res. 2021 Jan;197:77-83. doi: 10.1016/j.thromres.2020.10.033. Epub 2020 Nov 6. | |
| 32091505 | 0 | Roberge G, Carrier M. How to manage patients with symptomatic subsegmental pulmonary embolism? Pol Arch Intern Med. 2020 Apr 30;130(4):310-316. doi: 10.20452/pamw.15211. Epub 2020 Feb 24. | |
| 32056070 | 0 | Roberge G, Tritschler T, MacGillivray C, et al. Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report. J Thromb Thrombolysis. 2020 Oct;50(3):674-677. doi: 10.1007/s11239-020-02062-2. |
